Propanc Biopharma (PPCB) Live Share Price, Invest From India

Propanc Biopharma Stock Performance

as on October 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.33
Day's Price Range
$0.40
$0.34
3.51%
Downside
16.96%
Upside
52 Week's Low
52 Week's High
$0.33
52-Week Price Range
$41.25
$0.34
4.97%
Downside
11961.40%
Upside

Propanc Biopharma share price movements today

Previous Close: $0.34
Open: $0.35
Volume: 1.6M
Market Cap: $3.4M
Day's Low - High: $0.33 - $0.40
52 Week Low - High: $0.33 - $41.25

Propanc Biopharma Historical Returns

1 Month Return: -45.71 %
3 Month Return: -77.05 %
1 Year Return: -99.13 %
3 Year Return: -100 %
5 Year Return: 0 %

Propanc Biopharma Stock Fundamentals & Key Indicators

Check Propanc Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4M

EPS (TTM)

-25.63

Dividend Yield

0.00%

PE Ratio (TTM)

-0.01

Industry PE ratio

-3.95

PEG Ratio

-0.00

Return On Equity TTM

-167.51%

Propanc Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Propanc Biopharma with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Propanc Biopharma	NA	$3.4M	NA	-0.01	0.00%	0.00%
Moderna	Neutral	$94.4B	-32.76%	-29.64	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.9B	174.93%	29.37	86.04%	0.00%
Regeneron	Buy	$80.1B	42.93%	19.01	84.86%	0.46%

Stock Returns calculator for Propanc Biopharma Stock including INR - Dollar returns

The Propanc Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Propanc Biopharma investment value today

Current value as on today

₹936

Returns

-₹99,064

(-99.06%)

Returns from Propanc Biopharma Stock

-₹99,134 (-99.13%)

Dollar Impact

₹70 (+0.07%)

Indian Investors' Interest in Propanc Biopharma Stock

Search interest for Propanc Biopharma Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 19, 2026 to October 19, 2026

Change:-67% versus previous 30 day period

Propanc Biopharma Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	0
Operating Income	0	0	0	0	-53	-3	-4	-3	-6	-3
EBITDA	0	0	0	0	-53	-3	-4	-3	-6	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	0	0	0	0	-54	-4	-4	-3	-6	-4
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	0	0	0	0	-54	-4	-4	-3	-6	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Propanc Biopharma Annual Profit & Loss

All numbers in Millions USD

	Jun 2017	Jun 2018	Sep 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	-	-
Operating Income	-5	-3	-2	-3	-1	-1	-1	-1	-57	-18
EBITDA	-4	-4	-4	-3	-1	-2	-2	-1	-58	-18
Interest Expense	3	2	1	1	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-7	-5	-4	-2	-2	-2	-1	-58	-18
Income Tax Expense	0	0	0	0	0	0	0	0	-	-
Net Income	-7	-7	-5	-4	-2	-2	-2	-1	-58	-18
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Propanc Biopharma Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	0	0	0	0	-54	-4	-4	-3	-6	-4
Operating Cash Flow	0	0	0	0	0	0	-1	-1	-1	-1
Investing Cash Flow	-	-	-	-	-	-	0	0	0	0
Financing Cash Flow	0	0	0	0	0	0	2	0	0	2
Change in Cash	0	0	0	0	0	0	0	0	0	0

Propanc Biopharma Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Sep 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Net Income	-7	-7	-5	-4	-2	-2	-2	-1	-58	-18
Operating Cash Flow	-2	-2	-2	-1	-1	-1	-1	0	0	-5
Investing Cash Flow	-	-	0	-	-	-	-	-	-	0
Financing Cash Flow	2	2	2	1	1	1	1	0	0	6
Change in Cash	-	-	-	-	0	0	0	0	0	0

Global Institutional Holdings in Propanc Biopharma

Check out the Institutions with significant holdings in Propanc Biopharma.

Funds	Holdings
XTX Topco Ltd	0.01%
Caitong International Asset Management Co., Limited.	0.00%
TWO SIGMA SECURITIES, LLC	0.00%
Marex Group Ltd	0.00%
UBS Group AG	0.00%

See all

Insights on Propanc Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 837.3%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 253.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PPCB stock has moved down by -29.6%

About Propanc Biopharma

Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officially changing its name to Propanc Biopharma, Inc. in April 2017. The company's headquarters are located in Camberwell, Australia.

Organisation	Propanc Biopharma
Headquarters	302, 6 Butler Street, Camberwell, VIC, 3124, AU
Industry	Biotechnology
CEO	James Nathanielsz

Key Management of Propanc Biopharma

Name	Title
Mr. James Nathanielsz	CEO & Executive Chairman
Ms. Jeannine Zimmerman	Chief Financial Officer
Prof. Klaus Kutz M.D.	Acting Chief Medical Officer & Member of Scientific Advisory Board

FAQs

What is Propanc Biopharma share price today?

Propanc Biopharma share price today is $0.34 as on October 17, 2026 at 8:46 am IST at the close of the market. Propanc Biopharma share today touched a day high of $0.40 and a low of $0.33.

What is the 52 week high and 52 week low for Propanc Biopharma share?

Propanc Biopharma share touched a 52 week high of $41.25 on October 20, 2025 and a 52 week low of $0.33 on October 16, 2026. Propanc Biopharma stock price today i.e. October 17, 2026 at 8:46 am IST is closed at $0.34,which is 99.17% down from its 52 week high and 5.23% up from its 52 week low.

What is Propanc Biopharma's market capitalisation today?

Propanc Biopharma market capitalisation is $0.00T as on October 17, 2026 at 8:46 am IST.

How to invest in Propanc Biopharma Stock (PPCB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Propanc Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Propanc Biopharma Stock (PPCB) from India?

Indian investors can start investing in Propanc Biopharma (PPCB) shares with as little as ₹94.959999084473 or $1 (as of October 19, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Propanc Biopharma stock (as per the Rupee-Dollar exchange rate as on October 19, 2026 at 5:40 am IST). Based on Propanc Biopharma share’s latest price of $0.34 as on October 17, 2026 at 8:46 am IST, you will get 29.2398 shares of Propanc Biopharma. Learn more about fractional shares .